Japanese drug maker Astellas Pharma Inc. has filed a patent infringement lawsuit against India’s Ranbaxy Laboratories over its plans to make a generic version of the prostate drug Flomax.
A Delaware district court is hearing arguments this week in French drug giant Sanofi-Aventis’ trademark infringement lawsuit against upstart Advancis Pharmaceutical Corp.
U.K. drug maker GlaxoSmithKline has agreed to settle a patent infringement lawsuit brought against Bentley Pharmaceuticals, Inc. in Spain over a generic version of its Paxil antidepressant.
Once again, GlaxoSmithKline has been accused of gaming the patent system to fend off generic competition for its popular antidepressant Paxil.
Lilly ICOS LLC has filed a complaint with the U.S. International Trade Commission against several internet-based companies offering imported generic versions of the impotence drug Cialis via mail order.
The U.S. Court of Appeals for the Federal Circuit has affirmed in part a jury verdict in medical device maker ArthroCare Corp.’s patent infringement lawsuit against rival Smith & Nephew, but revived Smith & Nephew’s countersuit based on antitrust claims against ArthroCare and Ethicon.
A New York federal judge has agreed to postpone a pretrial hearing in Sanofi-Aventis’ patent-infringement lawsuit against Apotex Inc. and Dr. Reddy's Laboratories Ltd. over Sanofi's Plavix.
A Delaware jury has awarded medical device maker Advanced Medical Optics, Inc. $94.8 million in damages in its patent infringement lawsuit against rival Alcon Manufacturing, Ltd. over equipment used during cataract surgery.
Senators Joseph Lieberman and Orrin Hatch have introduced the controversial BioShield II legislation, which would extend data exclusivity and patents for “a very large number of medicines” if drug companies develop biodefense countermeasures.
Drug maker Andrx Corp. has entered into a marketing rights agreement with Amphastar Pharmaceuticals for a generic version of Sanofi-Aventis’ Lovenox, a treatment for deep vein thrombosis.
Cephalon has dropped its patent infringement suit against Swiss drug maker Sandoz following that drugmaker's decision not to market a generic version of Cephalon's drug Provigil.
Anglo-Norwegian in-vitro diagnostics company Axis-Shield Plc has reached an out-of-court settlement with Competitive Technologies Inc. in their patent dispute over homocysteine test results.
Eli Lilly and Co. has filed a lawsuit to bar Israeli drug maker Teva Pharmaceutical Industries Ltd. from marketing a generic version of the anti-psychotic drug Symbyax.
Medical device maker Quidel will pay rival Inverness Medical Innovations, Inc. $17 million plus royalties under a cross-licensing agreement to settle their far-reaching patent dispute over diagnostic tests.
A federal judge has approved SmithKline Beecham's $65 million settlement of a class-action antitrust suit brought by consumers who accused the U.K. drug maker of filing "sham" patent lawsuits to delay generic competition for antidepressant Paxil.
Medical device maker Medtronic Inc. has agreed to settle a patent infringement lawsuit brought by biotech company Cytomedix Inc. by taking a license to use its therapy for wound-healing, Cytomedix said.
In a case with wide implications for settlements of patent disputes in the pharmaceutical industry, the U.S. Federal Trade Commission has asked the U.S. Court of Appeals for the 11th Circuit in Atlanta to reconsider a ruling by a three-judge panel last month that dismissed the agency’s complaints against Schering-Plough Corp.
German drug maker Altana AG and U.S. marketing partner Wyeth have filed a lawsuit to block India's Sun Pharmaceutical Industries Ltd. from selling a generic version of the ulcer treatment Protonix.
Medical device maker Medtronic Inc. has agreed to pay about $1.35 billion to Los Angeles surgeon Gary K. Michelson to end a patent dispute over spinal fusion technologies.
A decision by the European Court of Justice could slash patent duration for drugs in the European Union and cost drug companies millions in lost revenues.